# The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).

Study · id `cardio:ct-nct02998229` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02998229](<https://clinicaltrials.gov/study/NCT02998229>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT02998229

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

## Technical summary

Registry record NCT02998229. Allocation not applicable; no masking; primary purpose treatment. Start 2024-04-16 (actual); primary completion 2027-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT02998229, source copy `cardio:ctgov-nct02998229-2026-10-09`, retrieved 2026-11-18)
- Started: 2024-04-16 (actual) (ClinicalTrials.gov record NCT02998229, source copy `cardio:ctgov-nct02998229-2026-10-09`, retrieved 2026-11-18)
- Primary completion: 2027-08 (anticipated) (ClinicalTrials.gov record NCT02998229, source copy `cardio:ctgov-nct02998229-2026-10-09`, retrieved 2026-11-18)
- Completion: 2032-02 (anticipated) (ClinicalTrials.gov record NCT02998229, source copy `cardio:ctgov-nct02998229-2026-10-09`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT02998229, source copy `cardio:ctgov-nct02998229-2026-10-09`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02998229-2026-10-09`, retrieved 2026-11-18)

## The registry's words

- Brief title: The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
- Acronym: ARTISSE
- Condition: Intracranial Aneurysm
- Intervention (Device): Artisse™ Intrasaccular Device
- Lead sponsor: Medtronic Neurovascular Clinical Affairs
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)
- Registry lists this organization as the lead sponsor: Medtronic Neurovascular Clinical Affairs (`cardio:org-medtronic-neurovascular-clinical-affairs`)

## Provenance

Content hash: 43b50a8a5fce7bc8add5517d120f86e38c86285a83ef580afe51b2566fc2e2b2
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
